Christopher J Edwards

Summary

Affiliation: University of Southampton
Country: UK

Publications

  1. ncbi Molecular profile of peripheral blood mononuclear cells from patients with rheumatoid arthritis
    Christopher J Edwards
    The Kennedy Institute of Rheumatology Division, Imperial College School of Medicine, London, UK
    Mol Med 13:40-58. 2007
  2. ncbi Environmental factors and lupus: are we looking too late?
    C J Edwards
    Department of Rheumatology, Southampton University Hospitals NHS Trust, Southampton General Hospital, Southampton, UK
    Lupus 14:423-5. 2005
  3. ncbi Growth and infectious exposure during infancy and the risk of rheumatoid factor in adult life
    C J Edwards
    Department of Rheumatology, Southampton General Hospital, Tremona Road, Southampton SO16 6YD, UK
    Ann Rheum Dis 65:401-4. 2006
  4. ncbi Immunological therapies for rheumatoid arthritis
    Christopher J Edwards
    Department of Rheumatology, Southampton General Hospital, Tremona Road, Southampton, UK
    Br Med Bull 73:71-82. 2005
  5. ncbi Early environmental factors and rheumatoid arthritis
    C J Edwards
    Department of Rheumatology, Southampton General Hospital, Southampton, UK
    Clin Exp Immunol 143:1-5. 2006
  6. ncbi Infections in infancy and the presence of antinuclear antibodies in adult life
    C J Edwards
    Medical Research Council Epidemiology Resource Centre, Southampton, UK
    Lupus 15:213-7. 2006
  7. ncbi Commentary: statins and fracture--why the confusion?
    C J Edwards
    MRC Epidemiology Resource Centre, University of Southampton, Southampton, UK
    Int J Epidemiol 35:1312-3. 2006
  8. ncbi Early environmental exposure and the development of lupus
    C J Edwards
    Department of Rheumatology, Southampton University Hospitals NHS Trust, Southampton General Hospital, Tremona Road, Southampton, SO16 6YD, UK
    Lupus 15:814-9. 2006
  9. ncbi The importance of the disease process and disease-modifying antirheumatic drug treatment in the development of septic arthritis in patients with rheumatoid arthritis
    Christopher J Edwards
    University of Southampton, and Southampton General Hospital, Southampton, UK
    Arthritis Rheum 57:1151-7. 2007
  10. ncbi The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis from the United Kingdom General Practice Research Database
    C J Edwards
    MRC Epidemiology Resource Centre, University of Southampton, Southampton General Hospital, Southampton SO16 6YD, UK
    Rheumatology (Oxford) 44:1394-8. 2005

Collaborators

Detail Information

Publications38

  1. ncbi Molecular profile of peripheral blood mononuclear cells from patients with rheumatoid arthritis
    Christopher J Edwards
    The Kennedy Institute of Rheumatology Division, Imperial College School of Medicine, London, UK
    Mol Med 13:40-58. 2007
    ..3. These results suggest that analysis of RA PBMCs at the molecular level may provide a set of candidate genes that could yield an easily accessible gene signature to aid in early diagnosis and treatment...
  2. ncbi Environmental factors and lupus: are we looking too late?
    C J Edwards
    Department of Rheumatology, Southampton University Hospitals NHS Trust, Southampton General Hospital, Southampton, UK
    Lupus 14:423-5. 2005
  3. ncbi Growth and infectious exposure during infancy and the risk of rheumatoid factor in adult life
    C J Edwards
    Department of Rheumatology, Southampton General Hospital, Tremona Road, Southampton SO16 6YD, UK
    Ann Rheum Dis 65:401-4. 2006
    ..The immune pathology leading to RA and RF may have similar genetic and environmental influences...
  4. ncbi Immunological therapies for rheumatoid arthritis
    Christopher J Edwards
    Department of Rheumatology, Southampton General Hospital, Tremona Road, Southampton, UK
    Br Med Bull 73:71-82. 2005
    ..There has also been an important proof of principle that blocking single cytokines can produce profound effects in inflammatory diseases...
  5. ncbi Early environmental factors and rheumatoid arthritis
    C J Edwards
    Department of Rheumatology, Southampton General Hospital, Southampton, UK
    Clin Exp Immunol 143:1-5. 2006
    ..We review the evidence that the early environment through effects on growth and infectious exposure may influence the likelihood of developing autoimmune diseases such as RA...
  6. ncbi Infections in infancy and the presence of antinuclear antibodies in adult life
    C J Edwards
    Medical Research Council Epidemiology Resource Centre, Southampton, UK
    Lupus 15:213-7. 2006
    ..56, P = 0.03) between one and five years of age. Our results suggest that a developing immune system exposed to increased infection is more likely to produce ANA in adult life and perhaps begin the pathological process that leads to SLE...
  7. ncbi Commentary: statins and fracture--why the confusion?
    C J Edwards
    MRC Epidemiology Resource Centre, University of Southampton, Southampton, UK
    Int J Epidemiol 35:1312-3. 2006
  8. ncbi Early environmental exposure and the development of lupus
    C J Edwards
    Department of Rheumatology, Southampton University Hospitals NHS Trust, Southampton General Hospital, Tremona Road, Southampton, SO16 6YD, UK
    Lupus 15:814-9. 2006
    ..We describe how early life environmental influences including infectious exposure may lead to autoantibody production in later life thus beginning the journey that leads to autoimmune diseases such as lupus in susceptible individuals...
  9. ncbi The importance of the disease process and disease-modifying antirheumatic drug treatment in the development of septic arthritis in patients with rheumatoid arthritis
    Christopher J Edwards
    University of Southampton, and Southampton General Hospital, Southampton, UK
    Arthritis Rheum 57:1151-7. 2007
    ..To evaluate the effect of disease-modifying antirheumatic drugs (DMARDs) on the likelihood of patients with rheumatoid arthritis (RA) developing septic arthritis (SA)...
  10. ncbi The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis from the United Kingdom General Practice Research Database
    C J Edwards
    MRC Epidemiology Resource Centre, University of Southampton, Southampton General Hospital, Southampton SO16 6YD, UK
    Rheumatology (Oxford) 44:1394-8. 2005
    ..To describe the use of disease-modifying anti-rheumatic drugs (DMARDs) in the treatment of rheumatoid arthritis (RA) and changing trends in their use...
  11. ncbi The presence of anticardiolipin antibodies in adults may be influenced by infections in infancy
    C J Edwards
    Department of Rheumatology, Southampton General Hospital, Tremona Road, Southampton, UK
    QJM 101:41-7. 2008
    ..We measured anticardiolipin antibodies (aCL) in a general population with well-defined early lives to see whether fetal and infant growth and infections were associated with aCL positivity in adult life...
  12. ncbi Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review
    Sarah L Westlake
    Department of Rheumatology, Southampton General Hospital, Tremona Road, Southampton SO16 6YD, UK
    Rheumatology (Oxford) 50:518-31. 2011
    ..However, the extent to which these agents also reduce cardiovascular disease (CVD) is uncertain. The purpose of this study was to explore the effect of anti-TNF agents on CVD in RA using a systematic literature review...
  13. ncbi Statins and bone morphogenetic proteins: new pathways in bone formation
    C J Edwards
    Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital
    Ann Acad Med Singapore 31:245-7. 2002
    ..This review outlines new evidence that the cholesterol synthetic pathway may be important in bone metabolism and that 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors or statins may increase bone formation...
  14. ncbi Statins as modulators of bone formation
    Christopher J Edwards
    Department of Rheumatology, Southampton General Hospital, Southampton, UK
    Arthritis Res 4:151-3. 2002
    ..In addition, the demonstration that statins can inhibit inflammation and encourage angiogenesis offers other possibilities for action...
  15. ncbi The role of interleukin-6 in rheumatoid arthritis-associated osteoporosis
    C J Edwards
    Department of Rheumatology, Southampton University Hospital, Tremona Road, Southampton, SO16 6YD, UK
    Osteoporos Int 21:1287-93. 2010
    ..Osteoporosis is highly prevalent in patients with rheumatoid arthritis (RA) and is a frequent cause of fractures, disability, reduced quality of life and increased use of healthcare resources...
  16. ncbi Hospitalization of individuals with systemic lupus erythematosus: characteristics and predictors of outcome
    C J Edwards
    Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore
    Lupus 12:672-6. 2003
    ..Young patients with frequent readmissions and coexistent infections are most likely to die...
  17. ncbi The autoantibody rheumatoid factor may be an independent risk factor for ischaemic heart disease in men
    C J Edwards
    MRC Epidemiology Resource Centre, University of Southampton, Southampton, UK
    Heart 93:1263-7. 2007
    ..This is most likely in those people with the autoantibody rheumatoid factor (RF). RF is strongly associated with rheumatoid arthritis (RA) but is also present in up to 15% of all adults...
  18. ncbi The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review
    Sarah L Westlake
    Department of Rheumatology, Poole Hospital NHS Foundation Trust, Poole, UK
    Rheumatology (Oxford) 49:295-307. 2010
    ..This is due to traditional risk factors and the effects of chronic inflammation. MTX is the first-choice DMARD in RA. We performed a systematic literature review to determine whether MTX affects the risk of CVD in patients with RA...
  19. ncbi Improvement in symptoms and signs in the forefoot of patients with rheumatoid arthritis treated with anti-TNF therapy
    Catherine J Bowen
    School of Health Sciences, University of Southampton, Southampton, UK
    J Foot Ankle Res 3:10. 2010
    ..The aim of this study was to evaluate whether anti-TNF therapy alters the presence of forefoot pathology and/or reduces foot pain and disability...
  20. ncbi Musculoskeletal ultrasound imaging of the plantar forefoot in patients with rheumatoid arthritis: inter-observer agreement between a podiatrist and a radiologist
    Catherine J Bowen
    School of Health Professions and Rehabilitation Sciences, University of Southampton, Southampton, UK
    J Foot Ankle Res 1:5. 2008
    ....
  21. ncbi Forefoot pathology in rheumatoid arthritis identified with ultrasound may not localise to areas of highest pressure: cohort observations at baseline and twelve months
    Catherine J Bowen
    Faculty of Health Sciences, University of Southampton, Southampton, UK
    J Foot Ankle Res 4:25. 2011
    ..abstract:..
  22. ncbi Anti-TNF-induced lupus
    Emma L Williams
    Department of Rheumatology, Southampton General Hospital, Southampton, UK
    Rheumatology (Oxford) 48:716-20. 2009
    ..Concomitant immunosuppression can reduce autoantibody formation in ATIL, and withdrawal of anti-TNF-alpha therapy usually leads to resolution of symptoms. Steroids and/or immunosuppressive therapy may be required in severe cases...
  23. ncbi Contemporary treatment principles for early rheumatoid arthritis: a consensus statement
    Patrick D W Kiely
    Department of Rheumatology, St Georges Healthcare NHS Trust, London, UK
    Rheumatology (Oxford) 48:765-72. 2009
    ..RA has a substantial impact on both patients and healthcare systems. Our objective is to advance the understanding of modern management principles in light of recent evidence concerning the condition's diagnosis and treatment...
  24. ncbi Reversible acute gastrointestinal syndrome associated with active systemic lupus erythematosus in patients admitted to hospital
    T Y Lian
    Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore
    Lupus 12:612-6. 2003
    ..The conclusions are that active SLE may manifest as an acute gastrointestinal syndrome. Early diagnosis, bowel rest, supportive medical therapy and treatment with corticosteroids and/or immunosupressives can result in a good outcome...
  25. ncbi The influence of early life factors on the risk of developing rheumatoid arthritis
    A N Colebatch
    Department of Rheumatology, Southampton General Hospital, and University of Southampton School of Medicine, Tremona Road, Southampton, UK
    Clin Exp Immunol 163:11-6. 2011
    ..There has also been a suggestion that the risk of RA is reduced in breast-fed infants. We describe the evidence surrounding the effect of early life factors on the risk of developing RA and possible mechanisms by which they may act...
  26. ncbi Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis)
    Alexandra N Colebatch
    Department of Rheumatology, Southampton General Hospital, Tremona Road, Southampton Consultant Rheumatologist Yeovil District Hospital, Somerset, Hampshire, UK, SO16 6YD
    Cochrane Database Syst Rev 11:CD008872. 2011
    ..There have been concerns regarding the safety of using concurrent non-steroidal anti-inflammatory drugs (NSAIDs), including aspirin, or paracetamol (acetaminophen), or both, in these people...
  27. ncbi Pain management for rheumatoid arthritis and cardiovascular or renal comorbidity
    Jonathan L Marks
    Department of Rheumatology, Southampton General Hospital, Tremona Road, Southampton, Hampshire, UK, SO16 6YD
    Cochrane Database Syst Rev 10:CD008952. 2011
    ..There are concerns that some of the pain pharmacotherapies currently used may increase the risk of adverse events in people with rheumatoid arthritis and concurrent cardiovascular or renal disease...
  28. ncbi Assessment of the natural history of forefoot bursae using ultrasonography in patients with rheumatoid arthritis: a twelve-month investigation
    Catherine J Bowen
    University of Southampton, Southampton University Hospitals National Health Service Trust, Southampton, UK
    Arthritis Care Res (Hoboken) 62:1756-62. 2010
    ..To determine the natural history and clinical significance of forefoot bursae over a 12-month period in patients with rheumatoid arthritis (RA)...
  29. ncbi Statins and bone: myth or reality?
    C J Edwards
    The Kennedy Institute of Rheumatology, Imperial College School of Medicine, London, UK
    Calcif Tissue Int 69:63-6. 2001
    ..These observations offered a new insight into the potential importance of the cholesterol synthesis pathway in bone turnover and future therapeutic opportunities...
  30. ncbi The effects of hormone replacement therapy on autoimmune disease: rheumatoid arthritis and systemic lupus erythematosus
    C R Holroyd
    Rheumatology Department, Southampton University Hospitals NHS Trust, Southampton, UK
    Climacteric 12:378-86. 2009
    ..In all individuals with autoimmune disease, the risk of venous thrombosis associated with oral HRT is an important factor that should also be considered...
  31. ncbi Low-dose pulse methylprednisolone for systemic lupus erythematosus flares is efficacious and has a decreased risk of infectious complications
    H Badsha
    Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore
    Lupus 11:508-13. 2002
    ..19-312.98) and a trend towards greater numbers of infections. Low-dose MEP was effective in controlling SLE flares and associated with fewer serious infections than traditional high-dose MEP...
  32. ncbi Melioidosis in systemic lupus erythematosus: the importance of early diagnosis and treatment in patients from endemic areas
    H Badsha
    Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore
    Lupus 10:821-3. 2001
    ..They also illustrate how successful outcomes can be achieved in a frequently fatal disease if an early diagnosis is made and appropriate antibiotics are started promptly...
  33. ncbi Bone morphogenetic proteins in the development and healing of synovial joints
    C J Edwards
    Kennedy Institute of Rheumatology, Imperial College School of Medicine, London, England, UK
    Semin Arthritis Rheum 31:33-42. 2001
    ..To review current knowledge of the role of bone morphogenetic proteins (BMPs) in joint formation and how this may be relevant to healing in adult joints...
  34. ncbi Hughes syndrome (the antiphospholipid syndrome): 25 years old
    C J Edwards
    Department of Rheumatology, Southampton University Hospitals, Southampton, UK
    Mod Rheumatol 18:119-24. 2008
    ..The advent of newer "biologic" immunosuppressives such as rituximab may offer help in selected cases. Intravenous immunoglobulin has proved successful, especially in the emergency setting...
  35. ncbi Primary meningococcal arthritis and endogenous endophthalmitis: a case report
    Y K Cheng
    Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore 308433
    Ann Acad Med Singapore 32:706-9. 2003
    ..We report the first patient with both PMA and meningococcal endophthalmitis and present a review of the literature...
  36. ncbi Myocardial infarction in a young man with antiphospholipid syndrome and cocaine use
    E L Williams
    Rheumatology Department, Southampton University Hospitals NHS Trust, Southampton, UK
    Lupus 16:444-6. 2007
    ..This case suggests the presence of a synergistic effect between cocaine and antiphospholipid antibodies...
  37. ncbi Study of infliximab treatment in asthma
    Christopher J Edwards
    Am J Respir Crit Care Med 175:196; author reply 196-7. 2007
  38. ncbi Intravenous pulses of methylprednisolone for systemic lupus erythematosus
    Humeira Badsha
    Department of Rheumatology, Tan Tock Seng Hospital, Singapore
    Semin Arthritis Rheum 32:370-7. 2003
    ..However, the gold standard 1 g/day for 3 consecutive days is associated with significant infectious complications and lower doses may be just as useful...